Clinical Trial

Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Recruiting
View on ClinicalTrials.gov →
Summary
This is a single-arm, open-label, exploratory clinical study to evaluate the safety, tolerability and preliminary efficacy of Anti-Mesothelin CAR-T cell injection in patients with Mesothelin-positive advanced malignant solid tumors.
Protocol Amendment History 1 change
notable Sponsor changed: Zhejiang University -> First Affiliated Hospital of Zhejiang University 2026-08-09
Trial Details
NCT Number NCT07010523
Lead Sponsor Zhejiang University
Collaborators: UTC Therapeutics Inc.
Conditions Mesothelin-positive Advanced Malignant Solid Tumors
Enrollment 24 participants
Start Date 2024-10-15
Primary Completion 2026-10-14 (estimated)
Study Completion 2027-10-14 (estimated)
Updated on ClinicalTrials.gov 2025-06-08